Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety.
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety.
复制标题
DOI:
10.1016/j.bmc.2012.11.017
复制
发表时间:
2013-01-15
影响因子:
3.5
通讯作者:
Hayashi Y
中科院分区:
文献类型:
--
作者:
Konno S;Thanigaimalai P;Yamamoto T;Nakada K;Kakiuchi R;Takayama K;Yamazaki Y;Yakushiji F;Akaji K;Kiso Y;Kawasaki Y;Chen SE;Freire E;Hayashi Y
We describe here the design, synthesis and biological evaluation of a series of molecules toward the development of novel peptidomimetic inhibitors of SARS-CoV 3CLpro. A docking study involving binding between the initial lead compound 1 and the SARS-CoV 3CLpro motivated the replacement of a thiazole with a benzothiazole unit as a warhead moiety at the P1′ site. This modification led to the identification of more potent derivatives, including 2i, 2k, 2m, 2o, and 2p, with IC50 or Ki values in the submicromolar to nanomolar range. In particular, compounds 2i and 2p exhibited the most potent inhibitory activities, with Ki values of 4.1 and 3.1 nM, respectively. The peptidomimetic compounds identified through this process are attractive leads for the development of potential therapeutic agents against SARS. The structural requirements of the peptidomimetics with potent inhibitory activities against SARS-CoV 3CLpro may be summarized as follows: (i) the presence of a benzothiazole warhead at the S1′-position; (ii) hydrogen bonding capabilities at the cyclic lactam of the S1-site; (iii) appropriate stereochemistry and hydrophobic moiety size at the S2-site and (iv) a unique folding conformation assumed by the phenoxyacetyl moiety at the S4-site.
登录
查看更多内容
影响因子:
1.8
作者:
Tian, QP;Nayyar, NK;Kennedy, TP
通讯作者:
Kennedy, TP
DOI:
10.1016/s0140-6736(03)13077-2
发表时间:
2003-04-19
期刊:
Lancet (London, England)
影响因子:
--
作者:
Peiris JS;Lai ST;Poon LL;Guan Y;Yam LY;Lim W;Nicholls J;Yee WK;Yan WW;Cheung MT;Cheng VC;Chan KH;Tsang DN;Yung RW;Ng TK;Yuen KY;SARS study group
通讯作者:
SARS study group
影响因子:
2.9
作者:
Barrila, Jennifer;Bacha, Usman;Freire, Ernesto
通讯作者:
Freire, Ernesto
影响因子:
56.9
作者:
Anand, K;Ziebuhr, J;Hilgenfeld, R
通讯作者:
Hilgenfeld, R
影响因子:
2.1
作者:
Sydnes, Magne O.;Hayashi, Yoshio;Kiso, Yoshiaki
通讯作者:
Kiso, Yoshiaki